Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).
Josefsson A, Jellvert Å, Holmberg E, Brasso K, Meidahl Petersen P, Aaltomaa S, Luukkaa M, Verhagen P, de Wit R, Ahlgren G, Andrén O, Castellanos E, Seke M, Widmark A, Damber JE; SPCG14-investigators. Josefsson A, et al. Among authors: ahlgren g. Acta Oncol. 2023 Apr;62(4):372-380. doi: 10.1080/0284186X.2023.2199940. Epub 2023 Apr 19. Acta Oncol. 2023. PMID: 37073813 Clinical Trial.
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andrén O, Bill-Axelson A, Bratt O, Damber JE, Hellström K, Hellström M, Holmberg E, Holmberg L, Hugosson J, Johansson JE, Petterson B, Törnblom M, Widmark A, Stattin P. Adolfsson J, et al. Among authors: ahlgren g. Scand J Urol Nephrol. 2007;41(6):456-77. doi: 10.1080/00365590701673625. Scand J Urol Nephrol. 2007. PMID: 17934985
Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial.
Solberg A, Widmark A, Tasdemir I, Ahlgren G, Angelsen A. Solberg A, et al. Among authors: ahlgren g. Scand J Urol Nephrol. 2011 Sep;45(4):233-8. doi: 10.3109/00365599.2011.560577. Epub 2011 Mar 31. Scand J Urol Nephrol. 2011. PMID: 21452932 Clinical Trial.
[Go for MRI in the diagnosis of prostate cancer].
Bratt O, Ahlgren G, Andrén O, Blomqvist L, Carlsson S, Damber JE, Hugosson J, Jäderling F, Karlsson CT, Robinson D. Bratt O, et al. Among authors: ahlgren g. Lakartidningen. 2015 Apr 20;112:DFZ3. Lakartidningen. 2015. PMID: 25898386 Free article. Swedish. No abstract available.
Achievements and perspectives in prostate cancer phase 3 trials from genitourinary research groups in Europe: introducing the Prostate Cancer Consortium in Europe.
Fizazi K, Abrahamsson PA, Ahlgren G, Bellmunt J, Castellano D, Culine S, de Wit R, Gillessen S, Gschwend JE, Hamdy F, James N, McDermott R, Miller K, Wiegel T, Wirth M, Tombal B. Fizazi K, et al. Among authors: ahlgren g. Eur Urol. 2015 May;67(5):904-12. doi: 10.1016/j.eururo.2014.08.076. Epub 2014 Sep 11. Eur Urol. 2015. PMID: 25218582
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.
Ahlgren GM, Flodgren P, Tammela TLJ, Kellokumpu-Lehtinen P, Borre M, Angelsen A, Iversen JR, Sverrisdottir A, Jonsson E, Sengelov L; Investigators of the Scandinavian Prostate Cancer Study Number 12. Ahlgren GM, et al. Eur Urol. 2018 Jun;73(6):870-876. doi: 10.1016/j.eururo.2018.01.012. Epub 2018 Feb 1. Eur Urol. 2018. PMID: 29395502 Clinical Trial.
53 results